Introduction
============

Radioelectric asymmetric conveyor (REAC) technology is designed to optimize ion fluxes at the molecular level that will drive the molecular mechanisms leading to cellular asymmetry and cell polarity (CP).[@b1-cia-12-1471] Specific protocols of the REAC technology have been demonstrated to effectively induce direct cell reprogramming[@b2-cia-12-1471]--[@b5-cia-12-1471] and counteract the biological[@b6-cia-12-1471]--[@b9-cia-12-1471] and neurological[@b10-cia-12-1471]--[@b14-cia-12-1471] decay mechanisms linked to aging, such as the degenerative processes of articular cartilage.[@b15-cia-12-1471] In previous studies, REAC technology regenerative tissue optimization (TO-RGN) treatment has decreased nitric oxide and metalloproteinase-3 production in normal and osteoarthritis chondrocytes, while inducing an increase in synthesis of the proteoglycans that are key components of the articular cartilage matrix.[@b15-cia-12-1471] Moreover, REAC technology showed an interesting effect on hyaluronic acid (HA), which plays a fundamental role in CP and hydrodynamic processes, affording significant modulation of cell proliferation, migration, morphogenesis, and senescence.[@b9-cia-12-1471] Acting on endogenous HA and HA-binding proteins, REAC technology modulates CP and the intracellular environment.[@b9-cia-12-1471] Hence, REAC technology can modulate endogenous HA synthesis and exert antisenescence actions.[@b9-cia-12-1471] The aging process also affects healing of articular cartilage tissues and is a risk factor for the development of osteoarthritis. Aging reduces the hydration of articular cartilage as well as the mitotic activity and subsequent population size of chondrocytes, which are postmitotic cells more vulnerable to accumulation of aberrant proteins and metabolic waste. The aging-related changes are linked to CP dysregulation with attendant changes in the signaling pathways that control cellular homeostasis, activation, differentiation, and survival. Because REAC TO-RGN treatment has been shown in several studies to affect reparative and regenerative processes, the purpose of the present research was to assess the efficacy of the specific REAC TO-RGN treatment type C in healing experimental chondral lesions in an ovine animal model. The type of lesion studied, if \>3 mm in diameter, tends to increase in size and depth and does not lead to spontaneous repair with normal hyaline articular cartilage.[@b16-cia-12-1471] However, it leads to chondral defects within the articular cartilage, because the avascular nature of the tissue does not allow for tissue regeneration, filling, or repair. In fact, progenitor cells from the bloodstream or resident chondrocytes in articular cartilage cannot migrate to the lesion, and thus do not contribute to the reparative process. On the contrary, in osteochondral cartilage defects \<3 mm in diameter, the chondral layer allows access to bone marrow cells, thereby causing vascular damage. The consequent repair response generally begins with a hematoma and results in local production of fibrocartilage tissue that is poorly organized and mechanically inferior compared to the native tissue.[@b17-cia-12-1471] Our hypothesis is that REAC technology, acting by optimizing CP, can induce chondrocyte migration and proliferation to start the reparative and regenerative processes.

Materials and methods
=====================

Ethical considerations
----------------------

The animal care and use protocol was in accordance with Italian and European laws on animal treatment in scientific research (Italian Bioethical Committee, Law Decree on the Treatment of Animals in Research, January 27, 1992, No 116). The experimental operations were performed in compliance with established standards for animal welfare and testing (CIBASA approval by the University of Sassari and the Ministry of Health, protocol N° 25134 of 10/08/2012).

Experimental design
-------------------

This experimental work entailed using four 4-year old female Sardinian sheep, with an average weight of 38 kg. The sheep were clinically free of musculoskeletal diseases and underwent a mini arthrotomy of the articulation of the left and right knees, creating experimental lesions of the medial condyle of each site. The control sheep were left untreated, but only had lesions produced in the left knee ([Table 1](#t1-cia-12-1471){ref-type="table"}).

REAC technology
---------------

REAC technology for therapeutic use utilizes asymmetric radioelectric fields to optimize CP in biological structures, for specific biomodulation effects.[@b2-cia-12-1471]--[@b4-cia-12-1471],[@b8-cia-12-1471],[@b15-cia-12-1471] The asymmetric conveyer probe (ACP) is peculiar to this technology, constituting a physical link between the device and the patient's body. The ACP is applied on specific points or areas of the body and makes it possible to create an asymmetric radioelectric circuit in combination with the local electrical environment of the cells or tissues, thus concentrating induced radioelectric microcurrents. The ACP provides an electrical tension reference at the point where it is applied and acts therefore as a pole of attraction. The electrical tension reference is fixed and independent of the applied load (a characteristic of the tissues under treatment). As a result of the asymmetrically conveyed radioelectric microcurrents, the REAC technology is able to normalize existing current flows after their transmission has been altered and reduced quantitatively. The REAC device used in this study was B.E.N.E. (ASMED, Florence, Italy). The REAC treatment utilized in this study is named TO-RGN type C.

TO-RGN includes a set of treatment protocols that are carried out by the ACP applied on specific points or areas of the body.

Surgery
-------

The anesthesia protocol for all animals consisted of intravenous premedication with fentanyl at 5 mg/kg (Fentanest^®^ 0.1 mg/2 mL; Pfizer, New York, NY, USA) and diazepam at 0.3 mg/kg (Valium^®^ 10 mg/2 mL; Roche, Basel, Switzerland). Epidural anesthesia was administered at the sacral--coccygeal joint while the animal was in a sternal recumbent position, using a 22 g Quincke spinal needle to inject lidocaine at 2 mg/kg (Lidocaina^®^ 2%, 20 mg/mL; Pfizer). Beginning 15 minutes after the animals were premedicated, general anesthesia was induced with intravenous lidocaine at 1 mg/kg (Lidocaina 2%, 20 mg/mL; Pfizer) and intravenous thiopental at 5--7 mg/kg (Pentothal Sodium^®^ 1 g/50 mL; MSD Animal Health, New Jersy, USA) followed by intubation of the subject. General anesthesia was then maintained with sevoflurane (Sevo Flo^®^; Abbott, Chicago, IL, USA) of about 1.5% in O~2~ at 0.8 L/min during mechanical ventilation with volumetric control (Fabius GS; Dräger, Lübeck, Germany) at 12 breaths/min at tidal volumes needed to keep end tidal CO~2~ at 37--42 mmHg (Infinity Delta; Dräger). During the surgery, 0.9% NaCl was infused at 10 mL/kg/h. The animals were then placed in dorsal recumbency and arthrotomy of the knee joint was performed to expose the articular surface of the femoral condyles. After thorough disinfection of the skin and preparation of the operative field, the limb was positioned with the knee in full flexion to improve the slip to the bottom of the kneecap. A No 11 scalpel blade was used to perform a full-thickness incision 5 mm long in the medial side of the tibio-patellar ligament in the convexity of the medial femoral condyle, which was easily palpable transdermally. For the incision, a Gelpi self-retaining retractor was first placed in a distal--proximal location, while a second retractor was positioned perpendicular to the first. This technique exploits the elasticity of the tissues, and by using the Gelpi retractors, it was possible to expose about 1 cm^2^ of the surface of the femoral condyle ([Figure 1A](#f1-cia-12-1471){ref-type="fig"}). An osteochondral defect was thus created on the loading area of the medial femoral condyle of the left knee; the field of injury was of a size such as to effectively counter spontaneous healing, ie, it was of the "critical size" as suggested in the literature. For sheep, this critical size entails a cylindrical shape with a 6 mm diameter and a 2 mm depth, with sharp margins and localization to the femoral condyle. To standardize these lesions, a punch with diameter of 6 mm, normally used for osteochondral transplantations, was used. It rested on the joint surface and was gently rotated clockwise and counterclockwise, delimiting the borders of the surgical defect ([Figure 1B](#f1-cia-12-1471){ref-type="fig"}). The articular cartilage tissue within the area of the lesion was removed by milling with the cylindrical tip and finished with a curette applied to the surface of the bone to a depth of about 2 mm ([Figure 1C--E](#f1-cia-12-1471){ref-type="fig"}). Continuous irrigation with 0.9% NaCl was maintained throughout the surgery to avoid heating the articular cartilage in the area where the milling cutter was used or drying the articular surface by exposure to the room air. Then, reconstruction was performed "lege artis" using sutures in separate planes of the joint capsule and the skin with synthetic absorbable monofilament (Monocryl U.S.P. 4/0) ([Figure 1F and G](#f1-cia-12-1471){ref-type="fig"}).

Postoperative treatment
-----------------------

All subjects were housed postoperatively in small enclosures and treated with the 24 h REAC TO-RGN protocol for 7 consecutive days. The ACP probe was applied to both legs in the hip femoral--tibial--patellar region and was replaced every 12 h. After treatment, the animals were confined in small spaces so as to limit movement and then returned to pasture until euthanasia was performed at 6 months to complete the study. After surgery, all subjects were clinically evaluated daily during the first week of REAC TO-RGN treatment ([Figure 2A and B](#f2-cia-12-1471){ref-type="fig"}); following the removal of cutaneous suture points, the clinical evaluation of the animals took place once a week until euthanasia. All samples were subjected to macroscopic, histological, and immunohistochemical evaluation of the ultrastructure of the regenerated tissues and also assesses for their integration with the surrounding tissue.

Macroscopic assessment
----------------------

As mentioned in the "Postoperative treatment" section, the sheep were euthanized 6 months after treatment and both femoral condyles were exposed and transversely sectioned perpendicular to the articular surface about 1--2 cm deep to evaluate the quality of the newly formed tissue, and the changes were documented photographically. The regenerating tissue in the articular cartilage defects was also examined by two observers who both applied the semi-quantitative scoring system developed by the International Articular cartilage Repair Society and modified by the authors ([Table S1](https://www.dovepress.com/get_supplementary_file.php?f=140976.pdf)).[@b19-cia-12-1471] The resulting values were averaged. Observations were initially recorded as percentages (surface appearance, filling of the defect, and graft--host integration at the margins).

Histological and immunohistochemistry procedures
------------------------------------------------

Condylar articular defects were removed as osteochondral blocks (thickness: 0.5 cm; width: 2--3 cm; height: 1--2 cm; distance of cutting from edges of defect: 0.5 cm) by using a circular saw with water cooling of the blade to avoid overheating. It was important to evaluate the defect in all of its aspects, and therefore each defect was sectioned into two parts (A and B) and each part was scored ([Figure 3](#f3-cia-12-1471){ref-type="fig"}). The blocks were fixed in 10% neutral-buffered formalin for 2--4 days and were then transferred to a volume of a decalcification solution (1:1 acid citric/formic acid solution) about 20 times the volume of the samples and then placed on a magnetic stirrer for 2--4 days. Then, after washing the tissues in running tap water for 4--8 h to remove all traces of the decalcification solution, the samples were dehydrated as follows: alcohol 50% for an indefinite time (standby step); alcohol 80% for 4 h at 40°C; alcohol 90% for 4 h at 40°C; alcohol 100% for 4 h at 40°C; 3 steps in xylene of 1 h each at 40°C; and finally 3 steps for paraffin infiltration of 45 min each at 59°C. After embedding the tissue blocks in paraffin wax, they were mounted on a microtome and oriented to provide 3-µm sagittal sections of the surgical defect. Slices were mounted on 3-aminopropyltriethoxylane-pretreated slides to avoid detachment. To evaluate general tissue morphology, sections were stained with hematoxylin and eosin to evaluate the matrix articular cartilage composition; azan-Mallory staining to assess the presence, amount, and distribution of the collagen fibers; and Safranine-O stain to reveal the distribution of proteoglycans. All slides were processed together to prevent variations of histological processing.

To analyze the expression of type II collagen in the articular cartilage, the histological sections were deparaffinized, rehydrated, and incubated at 37°C with proteinase K to unmask the antigen binding sites. The endogenous peroxidases were blocked by 30 min of incubation in Dako REAL Peroxidase-Blocking Solution (S2023; Dako, Glostrup, Denmark), and the saturation of nonspecific binding sites was obtained using 2.5% normal horse serum (ImmPRESS reagent kit; Vector Labs, Burlingame, CA, USA) for 30 min at room temperature. Then, sections were incubated overnight at 4°C with a type II collagen rabbit polyclonal antibody (anti-collagen type II LS-C18868 LSBio) at a 1:20.000 dilution. After about 16h at 4°C, the sections were incubated for 30 min at room temperature with anti-mouse/rabbit secondary antibody peroxidase conjugate (MP-7500, ImmPRESS reagent kit Peroxidase; Vector Labs). After staining with 3,3′-diaminobenzidine (ImmPACT DAB; Vector Labs), tissues were counterstained with hematoxylin, cover-slipped with Eukitt Mounting MediumTM (BiOptica, Milan, Italy), and observed under light microscopy. The femoral condyle obtained from the untreated sheep served as positive control. Negative controls were those in which primary antibody was omitted. Lesions were recorded using a Nikon Ds-fi1 digital camera.

Evaluation of histological and immunohistochemical data
-------------------------------------------------------

The histological regeneration was evaluated independently by two observers using an articular cartilage repair grading system derived from Caplan et al,[@b18-cia-12-1471] and Pilichi et al[@b19-cia-12-1471] and modified by the authors' ([Table S2](https://www.dovepress.com/get_supplementary_file.php?f=140976.pdf)). The two values obtained for each sample were averaged.

Results
=======

Treated group -- Evaluation 6 months after REAC TO-RGN treatment
----------------------------------------------------------------

The macroscopic analysis after 6 months showed a similarity in the regeneration process of the two right and left condyles. The lesion appeared filled, though not completely, with newly generated tissue of the light opalescent color similar to that of healthy articular cartilage, which covered the underlying subchondral bone completely ([Figure 4A, F, K, and P](#f4-cia-12-1471){ref-type="fig"}). The newly formed tissue surface appeared to be quite regular, and the continuity with the healthy tissue appeared to be good, an index of acceptable integration with the margins of the lesion. No breakages or cracks in the newly formed tissue were seen. The macroscopic results for the two subjects showed scores of 20.75/24 and 16.25/24 points, with a mean value of 18.5/24 points ([Table 1](#t1-cia-12-1471){ref-type="table"}). The macroscopic observations were confirmed by histological examinations. In fact, after 6 months the subjects reached overall scores of 37.75/62 and 48/62 with a mean of 42.87/62 points ([Table 2](#t2-cia-12-1471){ref-type="table"}).

Histologically, the formation of immature hyaline articular cartilage covering the lesion in a uniform manner but with some slight irregularities and deformations of the surface was documented. Furthermore, the filling was not complete, consistent with the macroscopic observations. Actually, we did not observe significant differences between the articular cartilage harvested from the two sheep, as is revealed by these scores. The structure of the newly formed tissue has the characteristics of immature hyaline articular cartilage, with numerous isogenic proliferation groups both in the margins and in the center of the lesion as well as many active chondroblasts and chondrocytes. The integration with the bone looked good, and there were observable beginnings of ossification of the deep articular cartilage, and sketchy tidemarks (the junction between calcified and uncalcified cartilage) albeit intermittently. The subchondral bone showed signs of remodeling and ossification. There were no cavities or subchondral cysts. The specific coloration of the proteoglycan matrix deposition appeared good, as did the coloration of collagen II markings which were quite similar to that of the healthy articular cartilage in both the left and right condyle. The most interesting observations were seen with respect to bone morphology repairs. Here we observed nearly complete regeneration of subchondral bone in final structure, with little vascularization and with the ossification nuclei almost absent ([Figure 4](#f4-cia-12-1471){ref-type="fig"}). This finding was confirmed by the bone score that showed a gap of 29% between the treated and untreated subjects (6.88/9 vs 4.25/9 points, based on the mean value from all the samples). Furthermore, the morphologic findings showed a gap of 35.22% between the treated and untreated subjects (7.88/9 vs 4/9 points, based on the mean of all samples). In all of the observed samples, the tidemarks appeared irregular and incomplete, and the marking of the matrix was good, as we had already observed in the untreated samples. The mean of total score of the repair process of macro- and micro-REAC TO-RGN type C-treated subjects was 61.37/86 and 71.37%, respectively ([Tables 1](#t1-cia-12-1471){ref-type="table"}[](#t2-cia-12-1471){ref-type="table"}--[3](#t3-cia-12-1471){ref-type="table"}).

Untreated group evaluation after 6 months
-----------------------------------------

The untreated subjects' condyles showed a considerably delayed reparative process after 6 months compared to the subjects treated with REAC TO-RGN. Macroscopically, the lesions were filled incompletely and had irregular surface characteristics. In all the untreated condyles, a poor repair with large depressed areas covered by fibrous tissue occurred. In particular, the left condyles had a deep cavity that penetrated into the subchondral bone ([Figure 5A, F, K, and P](#f5-cia-12-1471){ref-type="fig"}). The presence of the cavities was confirmed histologically. In the left condyle, a fibrous tissue cover was found, with few chondrogenic elements. One condyle appeared to have obvious cysts ([Figure 5H and M](#f5-cia-12-1471){ref-type="fig"}). The matrix of the condyles showed a little staining and an evident absence of collagen II, in large part demonstrating a lack of articular cartilage formation. Moreover, the matrix deposition was not uniform and articular cartilage islands were immersed in fibrous tissue, which had detectable appearances without uniform indications of collagen II staining ([Figure 5E, J, O, and T](#f5-cia-12-1471){ref-type="fig"}). The extent of the bone remodeling was still sizeable, a sign that ossification had not yet happened. No development of tidemarks was observed in any of the condyles. The mean total score of macro- and micro-ossification of the untreated subjects was 41/86, with 47.67% of the repair process evident ([Tables 1](#t1-cia-12-1471){ref-type="table"}[](#t2-cia-12-1471){ref-type="table"}--[3](#t3-cia-12-1471){ref-type="table"}).

Discussion
==========

The regeneration of articular cartilage represents an important challenge, and so numerous approaches have been proposed to promote the repair process. Clinical treatment strategies like mosaicplasty, autologous chondrocyte injection, and microfractures have produced unsatisfactory long-term results.[@b20-cia-12-1471] In recent years, the availability of tissue engineered products has led to proposals for different biological substitutes to restore or improve functionality of damaged tissues. Biomaterial scaffolds can play a critical role by providing a 3-dimensional environment to support cell growth, matrix deposition, and tissue regeneration. Although biomaterials can provide excellent physiochemical properties that play a key role in guiding articular cartilage tissue regeneration in vitro, deterioration of articular cartilage regenerated at defect sites in vivo occurs frequently.[@b21-cia-12-1471]

For the past several years, the use and efficacy of physical treatments has been investigated for chondral pathologies. REAC technology treatments are one of these candidate strategies and have opened new therapeutic perspectives for reparative and regenerative orthopedic processes. REAC technology has previously shown that somatic cells can be directly reprogrammed to differentiate into alternative forms without first going through transformation back to stem/progenitor cells. In human skin fibroblasts, the REAC technology induced remarkable commitments to cardiac, neuronal, or skeletal muscle lineages. This included transcription of tissue-restricted genes, including *Mef2c*, *Tbx5*, *GATA4*, *Nkx2.5*, and prodynorphin for cardiac reprogramming, as well as *myoD* and neurogenin 1 for skeletal myogenesis and neurogenesis, respectively. Conversely, REAC treatment elicited a biphasic effect on a number of stemness-related genes, leading to early transcriptional increase of *Oct4*, *Sox2*, *cMyc*, *Nanog*, and *Klf4* within 6--20 h of treatment, followed by a downregulation at later times. The REAC action bypassed persistent reprogramming and induced a pluripotent stem cell-like state that involved the transcriptional induction of the NADPH oxidase subunit Nox4.

The REAC technology mechanism of action is based on CP optimization.[@b9-cia-12-1471],[@b22-cia-12-1471] CP is a universal biological phenomenon that has been implicated in cell differentiation, proliferation, and morphogenesis. The establishment and maintenance of correct CP is crucial for normal cell physiology and tissue homeostasis of chondrocytes as well.[@b23-cia-12-1471],[@b24-cia-12-1471]

This work was designed to investigate REAC TO-RGN type C timing and an administration protocol to treat aging-related damage and injuries caused by trauma in order to help elucidate regenerative processes occurring in articular cartilage for human medicine in a model where the zone of injury is of a size sufficient to effectively inhibit spontaneous healing. The choice of the sheep model was suggested by its extensive use previously for study of regenerative processes in articular cartilage tissue.[@b25-cia-12-1471]--[@b27-cia-12-1471] The choice to use only four animals, two treated and two controls, was made to minimize unnecessary harm, given that this was a preliminary study designed to gain information for the timing and administration of the TO-RGN type C. The duration of the protocol was limited to 6 months, the minimum time needed to evaluate an initial lesion repair.

Conclusion
==========

The results obtained in this preliminary study seem encouraging, both in terms of quantity and quality. In fact, the comparison of the scores obtained between the treated and untreated groups shows a positive score in favor of the REAC TO-RGN type C-treated group. The present work shows the efficacy of REAC TO-RGN type C as a therapeutic tool, among the other REAC RGN protocols, in the treatment of articular cartilage damages, although future investigations are needed.
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![Surgical phases.\
**Note:** Surgical phases: (**A**) mini arthrotomy, (**B**) double gelpi self-retaining retractor placement, (**C**--**E**) osteochondral defect (6 mm diameter and a 2-mm depth, with sharp margins and localization to the femoral condyle), (**F**) (**G**) reconstruction (performed "lege artis" with the suture in separate planes of the joint capsule and the skin with synthetic absorbable monofilament Monocryl U.S.P 4/0).](cia-12-1471Fig1){#f1-cia-12-1471}

![REAC TO-RGN treatment (**A**) right leg, (**B**) left leg.\
**Abbreviations:** REAC, radioelectric asymmetric conveyor; REAC TO-RGN, REAC technology regenerative tissue optimization.](cia-12-1471Fig2){#f2-cia-12-1471}

![Preparation of the condyles.\
**Notes:** Trimming of lesion; line section of lesion (**A**) and (**B**) half lesion.](cia-12-1471Fig3){#f3-cia-12-1471}

![Treated group: macro and histological observations of 2 condyles, sectioned in half (number 1 in images **A** and **K**: right hemicondyle; number 2 in images **F** and **P**: left hemicondyle).\
**Notes:** Macroscopic appearance: **A**, **F**, **K**, **P**. Histological appearance: **B**, **G**, **L**, **Q** haematoxylin and eosin staining; **C**, **H**, **M**, **R** azan-mallory staining; **D**, **I**, **N**, **S** safranine-O staining; **E**, **J**, **O**, **T** type II collagen immunostaining. Magnification ×20.](cia-12-1471Fig4){#f4-cia-12-1471}

![Untreated group: macro and histological observations of 2 condyles, sectioned in half (number 1 in images **A** and **K**: right hemicondyle; number 2 in images **F** and **P**: left hemicondyle).\
**Notes:** Macroscopic appearance: **A**, **F**, **K**, **P**. Histological appearance: **B**, **G**, **L**, **Q** haematoxylin and eosin staining; **C**, **H**, **M**, **R** azan-mallory staining; **D**, **I**, **N**, **S** safranine-O staining; **E**, **J**, **O**, **T** type II collagen immunostaining. Magnification ×20.](cia-12-1471Fig5){#f5-cia-12-1471}

###### 

Experimental design

  Period-groups   Number of sheep   Stifle joint (femoral condyle)   Treatment
  --------------- ----------------- -------------------------------- -----------------
  6 months        2                 Left                             REAC RGN type C
  Right           REAC RGN type C                                    
  6 months        2                 Left                             None
  Total           4                 6                                

**Abbreviations:** REAC, radioelectric asymmetric conveyor; RGN, regenerative treatment.

###### 

Macroscopical score

  --------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sheep                  Condyle               Half lesion   Surface   Section aspect   Total   Mean half lesions   Mean subject                               
  ---------------------- --------------------- ------------- --------- ---------------- ------- ------------------- -------------- ---- ---- ----- ------ ---- -------
  6 months treated       Left medial condyle   A\            2\        3\               4\      2\                  3\             2\   3\   3\    22\    21   20,75
                                               B             2         3                4       2                   2              1    3    3     20          

  Right medial condyle   A\                    2\            3\        3\               3\      2\                  2\             3\   3\   21\   20,5        
                         B                     2             3         3                3       1                   2              3    3    20                

  6 months treated       Left medial condyle   A\            2\        2\               3\      1\                  1\             1\   3\   3\    16\    16   16,25
                                               B             2         2                3       1                   1              1    3    3     16          

  Right medial condyle   A\                    2\            2\        2\               1\      1\                  1\             3\   3\   15\   16,5        
                         B                     2             2         2                2       2                   2              3    3    18                

  6 months untreated     Left medial condyle   A\            0\        1\               0\      0\                  0\             1\   3\   3\    8\          8
                                               B             0         1                0       0                   0              1    3    3     8           

  6 months untreated     Left medial condyle   A\            1\        1\               1\      1\                  3\             2\   3\   1\    13\         13
                                               B             1         1                1       1                   3              2    3    1     13          
  --------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Abbreviations:** % Fd, percent area of defect filled; S1, tissue aspect; S2, regularity; Grti, graft-recipient tissue integration; Sct1, depth; Sct2, tissue aspect; Sct3, subchondral cysts; Sct4, periarticular remodeling.

###### 

Microscopical score

  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------
  Sheep                  Cond                  Half lesion   Cart[a](#tfn3-cia-12-1471){ref-type="table-fn"}   Bone[b](#tfn4-cia-12-1471){ref-type="table-fn"}   Morph[c](#tfn5-cia-12-1471){ref-type="table-fn"}   Vasc[d](#tfn6-cia-12-1471){ref-type="table-fn"}   Deg[e](#tfn7-cia-12-1471){ref-type="table-fn"}   Infl   Matr[f](#tfn8-cia-12-1471){ref-type="table-fn"}   Tot    Mean half lesions   Mean subject
  ---------------------- --------------------- ------------- ------------------------------------------------- ------------------------------------------------- -------------------------------------------------- ------------------------------------------------- ------------------------------------------------ ------ ------------------------------------------------- ------ ------------------- --------------
  6 months treated       Left medial condyle   A\            2\                                                4\                                                6\                                                 0\                                                8\                                               3\     5\                                                28\    32                  37,75
                                               B             7                                                 6                                                 8                                                  0                                                 9                                                3      3                                                 36                         

  Right medial condyle   A\                    7\            6\                                                9\                                                1\                                                 10\                                               3\                                               4\     40\                                               43,5                       
                         B                     7             6                                                 8                                                 4                                                  12                                                3                                                7      47                                                                           

  6 months treated       Left medial condyle   A\            6\                                                9\                                                8\                                                 4\                                                10\                                              3\     7\                                                47\    45,5                48
                                               B             6                                                 7                                                 8                                                  3                                                 10                                               3      7                                                 44                         

  Right medial condyle   A\                    7\            9\                                                9\                                                7\                                                 11\                                               3\                                               7\     53\                                               50,5                       
                         B                     7             8                                                 7                                                 7                                                  9                                                 3                                                7      48                                                                           

  6 months untreated     Left medial condyle   A\            5\                                                4\                                                6\                                                 0\                                                12\                                              3\     4\                                                34\                        28,5
                                               B             2                                                 1                                                 5                                                  0                                                 8                                                3      4                                                 23                         

  6 months untreated     Left medial condyle   A\            6\                                                6\                                                2\                                                 3\                                                11\                                              0\     4\                                                32\                        32,5
                                               B             6                                                 6                                                 3                                                  3                                                 11                                               0      4                                                 33                         
  -----------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------------

**Notes:**

C1+C2+C3;

B1+B2;

Fd+Edg+Int+Tdk;

V1+V2;

D1+D2+D3+D4;

M1+M2+M3.

**Abbreviations:** Cart, cartilage; Cond, condyle; Deg, degeneration; Matr, matrix staining; Morph, morphology; Tot, total; Vasc, vascular; C1, surface regularity; C2, cell type; C3, tissue type; B1, ossification; B2, cell type; Fd, filling of defect; Edg, edges of defect; Int, integration between cartilage and bone plate; Tdk, tidemark, V1 amount; V2, distribution; D1, degree of articular deterioration; D2, subchondral bone sclerosis; D3, periarticular remodeling or lipping; D4, subchondral bone cysts; Inf, inflammation; Ms1, collagen staining with Azan-Mallory; Ms2, proteoglycan staining with Safranine--O; Ms3, collagen type II immunostaining.
